— Know what they know.
Not Investment Advice

IYXI OTC

Inyx, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 51 · $5234 mcap · 50M float · 0.0092% daily turnover

Income Trends

Revenue
$496M +3057.2% ▲
3Y CAGR: +1987.7%
Gross Profit
$461M +33217.9% ▲
3Y CAGR: +1937.6%
Operating Income
$21M +71.2% ▲
3Y CAGR: +501.4%
Net Income
-$31M -83.0% ▼
EPS (Diluted)
$-0.78 -50.0% ▼
EBITDA
-$16M -68.3% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2002FY2003FY2004FY2005
Revenue$54K$13M$16M$496M
YoY Growth+0.0%+23947.7%+19.8%+3057.2%
Cost of Revenue$0$11M$14M$35M
Gross Profit$54K$2M$1M$461M
Gross Margin100.0%18.8%8.8%93.0%
R&D Expenses$0$0$3M$3M
SG&A Expenses$129K$7M$10M$28M
Operating Expenses-$42K-$2M-$11M$440M
Operating Income$96K$5M$12M$21M
Operating Margin176.8%35.6%78.0%4.2%
Interest Expense$0$0$3M$10M
Income Before Tax-$113K-$14M-$16M-$31M
Tax Expense$0-$1M$1M$0
Net Income-$113K-$12M-$17M-$31M
Net Margin-207.6%-95.4%-107.9%-6.3%
EPS (Diluted)$-0.02$-0.59$-0.52$-0.78
EBITDA-$74K-$4M-$10M-$16M
Shares Outstanding5M23M33M40M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms